Analyze Diet

Advances in ELISA-based detection of equine leptospirosis.

Abstract: Leptospirosis is a globally distributed zoonosis that affects both humans and animals, with being the main causative agent. In horses, the disease is associated with considerable economic losses. The Microscopic Agglutination Test (MAT) is the reference test for diagnosis but has limitations, emphasizing the need for effective diagnostic alternatives. In this study, was evaluated the use of a recombinant chimera, composed of ErpY-like and LemA proteins, as an antigen for ELISA-based detection of equine leptospirosis. The chimera was successfully expressed, purified and tested on 915 horse serum samples previously analyzed by MAT. The ELISA correctly identified all positive samples, with no false negative observed. The ROC curve analysis, considering different hypothetical prevalence values, reached up to 0.92. The assay demonstrated sensitivity ranging from 98.8% to 100%, specificity from 77.6% to 84%, positive predictive value between 68.6% and 77.2%, and negative predictive value between 92% and 100%. The Kappa coefficient was 0.7432, indicating good agreement with MAT. When samples were categorized by titers, those with a 1:400 dilution achieved the highest accuracy (99%), while those with a 1:100 dilution showed slightly lower accuracy (94.8%), demonstrating that higher antibody titers resulted in a more effective assay. The major serovars that cause infection in horses, such as Bratislava, Icterohaemorrhagiae, Sejroe, Pomona, and Copenhageni, react with rErpY-lemA. These results suggest that the ErpY-LemA chimera is a promising screening tool for equine leptospirosis, offering a valuable alternative for the rapid and accurate detection of different serovars and titers. The test demonstrated high sensitivity and specificity, with strong agreement with the MAT (Kappa value). No false negatives were identified, further confirming the test’s reliability. This is the first study to use a recombinant chimera for equine leptospirosis diagnosis. The recombinant ErpY-LemA chimera was successfully used as an antigen in an ELISA-based assay for diagnosing equine leptospirosis, proving to be a promising screening tool. [Image: see text]
Publication Date: 2026-02-09 PubMed ID: 41663676PubMed Central: PMC12886683DOI: 10.1007/s42770-025-01854-zGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This research evaluated a new ELISA test for detecting leptospirosis in horses, using a recombinant protein chimera as an antigen, showing it to be a reliable alternative to the standard diagnostic method.

Background on Leptospirosis and Diagnosis Challenges

  • Leptospirosis is a widespread zoonotic disease affecting both humans and animals, including horses.
  • The disease in horses causes important economic impacts due to illness.
  • The current reference diagnostic method is the Microscopic Agglutination Test (MAT), which has limitations such as complexity, requirement of live cultures, and potential inaccuracies.
  • There is a need for effective, rapid, and accurate alternative diagnostic methods.

Development of the ELISA-Based Assay Using Recombinant Chimera

  • A recombinant chimera combining two Leptospira proteins, ErpY-like and LemA, was created to be used as the antigen in the ELISA test.
  • This chimera was successfully expressed and purified for use in diagnostics.
  • The purpose was to detect antibodies in horse serum samples, indicating leptospirosis infection.

Testing and Validation of the ELISA Assay

  • 915 horse serum samples previously tested with MAT were used to validate the ELISA test.
  • The ELISA assay correctly identified all positive cases, demonstrating zero false negatives.
  • Sensitivity of the test ranged from 98.8% to 100%, showing it is highly effective at identifying infected horses.
  • Specificity ranged from 77.6% to 84%, indicating a good ability to correctly identify non-infected horses.
  • Positive Predictive Value (PPV) ranged between 68.6% and 77.2%, meaning most positive results are true positives.
  • Negative Predictive Value (NPV) ranged between 92% and 100%, meaning negative results are highly reliable.
  • The ROC curve analysis showed an area under the curve (AUC) of up to 0.92, reflecting very good test accuracy.
  • The Kappa coefficient was 0.7432, indicating good agreement between ELISA and MAT results.

Performance by Antibody Titer Levels

  • Samples were grouped by antibody dilution titers to evaluate test accuracy at different infection levels.
  • Samples with a 1:400 dilution had the highest accuracy of 99%, showing the test works best with higher antibody concentrations.
  • Samples with a 1:100 dilution still had good accuracy at 94.8%, though slightly less than higher titers.
  • This suggests the ELISA test sensitivity improves with higher antibody levels in serum.

Spectrum of Leptospira Serovars Detected

  • The recombinant ErpY-LemA chimera reacted to antibodies against major equine-infecting Leptospira serovars: Bratislava, Icterohaemorrhagiae, Sejroe, Pomona, and Copenhageni.
  • This broad reactivity means the ELISA can effectively detect infections caused by multiple important serovars.

Conclusions and Significance

  • The study represents the first reported use of a recombinant chimera protein in diagnosing equine leptospirosis via ELISA.
  • The test offers a valuable alternative to the MAT, with advantages including rapidity, ease of use, and high sensitivity/specificity.
  • No false negatives occurred, highlighting the test’s reliability for screening purposes.
  • The recombinant ErpY-LemA-based ELISA is a promising screening tool that can improve surveillance and management of equine leptospirosis by enabling accurate and timely detection.

Cite This Article

APA
Cardoso TL, Wozeak DR, Pereira IL, da Silva Ribeiro LD, Rodrigues RO, Hartwig DD. (2026). Advances in ELISA-based detection of equine leptospirosis. Braz J Microbiol, 57(1), 52. https://doi.org/10.1007/s42770-025-01854-z

Publication

ISSN: 1678-4405
NlmUniqueID: 101095924
Country: Brazil
Language: English
Volume: 57
Issue: 1
Pages: 52
PII: 52

Researcher Affiliations

Cardoso, Thayná Laner
  • Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
  • Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
Wozeak, Daniela Rodriguero
  • Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
  • Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
Pereira, Isabel Ladeira
  • Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
  • Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
da Silva Ribeiro, Laura Dias
  • Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil.
  • Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil.
Rodrigues, Rogério Oliveira
  • Leptospirosis Laboratory, Department of Animal Diagnostics and Research, Secretariat of Agriculture, Livestock and Irrigation, Desidério Finamor Veterinary Research Institute, Eldorado do Sul, RS, Brazil.
Hartwig, Daiane Drawanz
  • Bacteriology and Bioassays Laboratory, Department of Microbiology and Parasitology, Institute of Biology, Federal University of Pelotas, Pelotas, RS, Brazil. daianehartwig@gmail.com.
  • Biotechnology Center, Biotechnology Development Center, Federal University of Pelotas, Pelotas, RS, CEP 96010-900, Brazil. daianehartwig@gmail.com.

Grant Funding

  • 001 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul / Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico / Conselho Nacional de Desenvolvimento Científico e Tecnológico

Conflict of Interest Statement

Declarations. Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper

References

This article includes 57 references
  1. Soo ZMP, Khan NA, Siddiqui R. Leptospirosis: increasing importance in developing countries.. Acta Trop .
  2. Adler B. Pathogenesis of leptospirosis: cellular and molecular aspects.. Vet Microbiol 172:353–358.
    doi: 10.1016/j.vetmic.2014.06.015pubmed: 24999234google scholar: lookup
  3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM. Leptospirosis: a zoonotic disease of global importance.. Lancet Infect Dis 3:757–771.
    doi: 10.1016/S1473-3099(03)00830-2pubmed: 14652202google scholar: lookup
  4. Bandara K, Weerasekera MM, Gunasekara C, Ranasinghe N, Marasinghe C, Fernando N. Utility of modified faine’s criteria in diagnosis of leptospirosis.. BMC Infect Dis 16:1–7.
    doi: 10.1186/s12879-016-1791-9pmc: PMC4995749pubmed: 27554098google scholar: lookup
  5. Musso D, La Scola B. Laboratory diagnosis of leptospirosis: a challenge.. J Microbiol Immunol Infect 46:245–252.
    doi: 10.1016/j.jmii.2013.03.001pubmed: 23639380google scholar: lookup
  6. Fávero JF, De Araújo HL, Lilenbaum W, Machado G, Tonin AA, Baldissera MD, Stefani LM, Da Silva AS. Bovine leptospirosis: prevalence, associated risk factors for infection and their cause-effect relation.. Microb Pathog 107:149–154.
    doi: 10.1016/j.micpath.2017.03.032pubmed: 28351712google scholar: lookup
  7. Lilenbaum W, Varges R, Brandão FZ, Cortez A, de Souza SO, Brandão PE, Richtzenhain LJ, Vasconcellos SA. Detection of spp. in semen and vaginal fluids of goats and sheep by polymerase chain reaction.. Theriogenology 69:837–842.
  8. Morais DDA, Costa DFD, Nunes BC, Santos CDSAB, Alves CJ, Azevedo SSD. Seroepidemiological survey for leptospirosis in equines from semiarid region of Paraíba state, Northeastern Brazil.. Semina: Ciências Agrárias 40:2079.
  9. Adler B, de la Peña Moctezuma A. and leptospirosis.. Vet Microbiol 140:287–296.
    doi: 10.1016/j.vetmic.2009.03.012pubmed: 19345023google scholar: lookup
  10. Levett PN. Leptospirosis.. 14: 296–326.
    pmc: PMC88975pubmed: 11292640doi: 10.1128/cmr.14.2.296google scholar: lookup
  11. Morais DA, Nunes BC, Barnabé NNC, Anjos DM, Bezerra CS, Costa DF, Santos CSAB, Azevedo SS, Alves CJ. Spatial and seasonal distribution of spp. seropositive horses in the Northeast region of Brazil.. Prev Vet Med 231:106301.
  12. Faisal SM, McDonough SP, Chang Y-F. Leptospira: Invasion, Pathogenesis and Persistence.. In: Embers ME (ed) Pathog. Spirochetes Strateg. Evasion Host Immun. Persistence. Springer US, Boston, MA, pp 143–172.
  13. Broux B, Torfs S, Wegge B, Deprez P, van Loon G. Acute respiratory failure caused by spp. in 5 foals.. J Vet Intern Med 26:684–687.
  14. Palaniappan RUM, Ramanujam S, Chang Y-F. Leptospirosis: pathogenesis, immunity, and diagnosis.. Curr Opin Infect Dis 20:284–292.
    doi: 10.1097/QCO.0b013e32814a5729pubmed: 17471039google scholar: lookup
  15. Petrakovsky J, Bianchi A, Fisun H, Nájera-Aguilar P, Pereira MM. Animal leptospirosis in Latin America and the Caribbean countries: reported outbreaks and literature review (2002–2014).. Int J Environ Res Public Health 11:10770–10789.
    doi: 10.3390/ijerph111010770pmc: PMC4211005pubmed: 25325360google scholar: lookup
  16. Zacarias FGDS, Vasconcellos SA, Anzai EK, Giraldi N, De Freitas JC, Hartskeerl R. Isolation of serovars Canicola and Copenhageni from cattle urine in the State of Paraná, Brazil.. Braz J Microbiol 39:744–748.
  17. Goris MGA, Hartskeerl RA. Leptospirosis serodiagnosis by the microscopic agglutination test.. Curr Protoc Microbiol 32.
  18. Yaakob Y, Rodrigues KF, John DV. Leptospirosis: recent incidents and available diagnostics– a review.. Med J Malaysia 70:351–355.
    pubmed: 26988208
  19. Alizadeh S, Abdollahpour G, Pourmand M, Naserpour T, Najafipour R, Eshraghi S. Evaluation of new ELISA based on rLsa63 - rLipL32 antigens for serodiagnosis of human Leptospirosis, Iran.. J Microbiol 6:184–189.
    pmc: PMC4393495pubmed: 25870752
  20. De Abreu Fonseca C, de Teixeira Freitas VL, Caló Romero E, Spinosa C, Arroyo Sanches MC, Da Silva MV, Shikanai-Yasuda MA. Polymerase chain reaction in comparison with serological tests for early diagnosis of human leptospirosis.. Trop Med Int Health 11:1699–1707.
  21. Lin X, Chen Y, Yan J. Recombinant multiepitope protein for diagnosis of leptospirosis.. Clin Vaccine Immunol 15:1711–1714.
    doi: 10.1128/CVI.00189-08pmc: PMC2583528pubmed: 18827193google scholar: lookup
  22. Mariya R, Chaudhary P, Kumar AA, Thangapandian E, Amutha R, Srivastava SK. Evaluation of a recombinant LipL41 antigen of serovar Canicola in ELISA for serodiagnosis of bovine Leptospirosis.. Comp Immunol Microbiol Infect Dis 29:269–277.
    doi: 10.1016/j.cimid.2006.06.007pubmed: 16979238google scholar: lookup
  23. Surujballi O, Mallory M. An indirect enzyme linked immunosorbent assay for the detection of bovine antibodies to multiple serovars.. Can J Vet Res 68:1–6.
    pmc: PMC1142122pubmed: 14979428
  24. Ye C, Yan W, McDonough PL, McDonough SP, Mohamed H, Divers TJ, Chang Y-F, Yang Z. Serodiagnosis of equine leptospirosis by enzyme-linked immunosorbent assay using four recombinant protein markers.. Clin Vaccine Immunol 21:478–483.
    doi: 10.1128/CVI.00649-13pmc: PMC3993115pubmed: 24451330google scholar: lookup
  25. Padilha BCR, Simão HQ, Collares TF, de Freitas SB, Oliveira TL, Schuch RA, Woloski RDS, Hartwig DD. ErpY-like protein, a promising antigen to leptospirosis control: characterization of antigenic and immunogenic potential.. Acta Sci Biol Sci 44:1–9.
  26. Ghosh KK, Prakash A, Dhara A, Hussain MS, Shrivastav P, Kumar P, Balamurugan V, Kumar M. Role of supramolecule ErpY-like lipoprotein of in thrombin-catalyzed fibrin clot inhibition and binding to complement factors H and I, and its diagnostic potential.. Infect Immun 87:e00536-19.
    doi: 10.1128/IAI.00536-19pmc: PMC6867842pubmed: 31548314google scholar: lookup
  27. Oliveira TL, Schuch RA, Inda GR, Roloff BC, Neto ACPS, Amaral M, Dellagostin OA, Hartwig DD. LemA and erp Y-like recombinant proteins from protect hamsters from challenge using AddaVax as adjuvant.. Vaccine 36:2574–2580.
    doi: 10.1016/j.vaccine.2018.03.078pubmed: 29625765google scholar: lookup
  28. Cardoso TL, de Freitas SB, Balassiano IT, Hartwig DD. Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection.. Braz J Microbiol .
    pmc: PMC11405570pubmed: 38805148
  29. Padilha BCR, Simão HQ, Oliveira TL, Hartwig DD. The use of ErpY-like recombinant protein from in the development of an immunodiagnostic test for swine leptospirosis.. Acta Trop 193:31–34.
  30. Hartwig DD, Odir AD, Grassmann AA, Félix SR, Da Silva ÉF, McBride AJA. Recombinant vaccines against leptospirosis.. Hum Vaccin 7:1215–1224.
    doi: 10.4161/hv.7.11.17944pubmed: 22048111google scholar: lookup
  31. Oliveira TL, Bacelo KL, Forster KM, Ilha V, Rodrigues OE, Hartwig DD. DNA nanovaccines prepared using LemA antigen protect golden Syrian hamsters against lethal infection. Mem Inst Oswaldo Cruz 115:1–6.
    doi: 10.1590/0074-02760190396pmc: PMC7164400pubmed: 32321154google scholar: lookup
  32. Hartwig DD, Forster KM, Oliveira TL, Amaral M, McBride AJA, Dellagostina OA. A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis. Clin Vaccine Immunol 20:747–752.
    doi: 10.1128/CVI.00034-13pmc: PMC3647757pubmed: 23515012google scholar: lookup
  33. Ávila-Martínez EG, Cardoso TL, Pereira IL, Caballero PS, Wozeak DR, Neto ACPS, da Silva Pinto L, Hartwig DD. Immunoinformatic approaches for ErpY-LemA chimeric protein design for use in leptospirosis control. J Appl Microbiol .
    doi: 10.1093/jambio/lxae179pubmed: 39020252google scholar: lookup
  34. Cardoso TL, Pereira IL, Wozeak DR, Neto ACPS, Balassiano IT, Hartwig DD. ErpY-LemA: a breakthrough in human leptospirosis diagnosis. Diagn Microbiol Infect Dis .
  35. Cardoso TL, Wozeak DR, Pereira IL, Dias NL, Pinto Seixas Neto AC, Rodrigues RO, Hartwig DD. Chimeric recombinant protein (rErpY-LemA) as innovative tools for animal leptospirosis serodiagnosis. Microb Pathog 205:107665.
    pubmed: 40348209doi: 10.1016/j.micpath.2025.107665google scholar: lookup
  36. Behera SK, Sabarinath T, Ganesh B, Mishra PKK, Niloofa R, Senthilkumar K, Verma MR, Hota A, Chandrasekar S, Deneke Y, Kumar A, Nagarajan M, Das D, Khatua S, Sahu R, Ali SA. Diagnosis of human leptospirosis: comparison of microscopic agglutination test with recombinant LigA/B antigen-based in-house IgM dot ELISA dipstick test and latex agglutination test using bayesian latent class model and MAT as gold standard. Diagnostics 12:1455.
    doi: 10.3390/diagnostics12061455pmc: PMC9221883pubmed: 35741265google scholar: lookup
  37. Dreyfus A, Ruf M-T, Goris M, Poppert S, Mayer-Scholl A, Loosli N, Bier NS, Paris DH, Tshokey T, Stenos J, Rajaonarimirana E, Concha G, Orozco J, Colorado J, Aristizábal A, Dib JC, Kann S. Comparison of the Serion IgM ELISA and microscopic agglutination test for diagnosis of spp. infections in sera from different geographical origins and estimation of seroprevalence in the Wiwa Indigenous population from Colombia. PLoS Negl Trop Dis 16:e0009876.
  38. Jalii IME. Comparison between ELISA and the microscopic agglutination test for the diagnosis of bovine leptospirosis. .
  39. Mulla S, Chakraborty T, Patel M, Pandya HP, Dadhaniya V, Vaghela G. Diagnosis of leptospirosis and comparison of ELISA and MAT techniques. Indian J Pathol Microbiol 49:468–470.
    pubmed: 17001926
  40. Sakhaee E, Abdollahpour G, Bolourchi M, Tabrizi SS. Comparison between microscopic agglutination test (MAT) and enzyme-linked immunosorbent assay (ELISA) for detection of leptospiral antibodies in cattle. Comp Clin Pathol 19:5–9.
    doi: 10.1007/s00580-009-0907-7google scholar: lookup
  41. Zin NM, Othman SN, Abd Rahman FR, Abdul Rachman AR. Evaluation of IgM LAT and IgM ELISA as compared to microscopic agglutination test (MAT) for early diagnosis of sp. Trop. Biomed. 36:1071–1080.
    pubmed: 33597476
  42. Martinez ML, Rodriguez MA, Irazu LE, Romero GN, Saraullo VR, Watanabe O, Hamer M, Grüne Loffler S, Samartino LE, Brihuega BF. New enzyme-linked immunoassay for the detection of specific antibodies against multiple serogroups in bovine sera. Comp. Immunol. Microbiol. Infect. Dis. 75:101609.
    doi: 10.1016/j.cimid.2021.101609pubmed: 33493976google scholar: lookup
  43. Fernandes LGV, Avelar KES, Romero EC, Heinemann MB, Kirchgatter K, Nascimento ALTO. A new recombinant multiepitope chimeric protein of is a promising marker for the serodiagnosis of leptospirosis. Trop Med Infect Dis 7:362.
    doi: 10.3390/tropicalmed7110362pmc: PMC9694704pubmed: 36355904google scholar: lookup
  44. Lewis FI, Torgerson PR. A tutorial in estimating the prevalence of disease in humans and animals in the absence of a gold standard diagnostic. Emerg Themes Epidemiol .
    doi: 10.1186/1742-7622-9-9pmc: PMC3558341pubmed: 23270542google scholar: lookup
  45. Iragorri N, Spackman E. Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis. Public Health Rev .
    doi: 10.1186/s40985-018-0093-8pmc: PMC6043991pubmed: 30009081google scholar: lookup
  46. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 37:360–363.
    pubmed: 15883903
  47. Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Casp J Intern Med 4:627–635.
    pmc: PMC3755824pubmed: 24009950
  48. Arent Z, Pardyak L, Dubniewicz K, Płachno B, Kotula-Balak M. taxonomy: then and now. Medycyna Wet 78:6694–2022.
    doi: 10.21521/mw.6694google scholar: lookup
  49. Verma A, Stevenson B, Adler B. Leptospirosis in horses. Vet Microbiol 167:61–66.
    doi: 10.1016/j.vetmic.2013.04.012pubmed: 23647816google scholar: lookup
  50. Maneewatchararangsri S, Doungchawee G, Kalambaheti T, Luvira V, Soonthornworasiri N, Vattanatham P, Chaisri U, Adisakwattana P. Evaluation of a genus-specific rGroEL1-524 IgM-ELISA and commercial ELISA kits during the course of leptospirosis in Thailand. Sci Rep 11:19785.
    doi: 10.1038/s41598-021-99377-8pmc: PMC8492722pubmed: 34611273google scholar: lookup
  51. Signorini ML, Lottersberger J, Tarabla HD, Vanasco NB. Enzyme-linked immunosorbent assay to diagnose human leptospirosis: a meta-analysis of the published literature. Epidemiol Infect 141:22–32.
    doi: 10.1017/S0950268812001951pmc: PMC9152066pubmed: 22953720google scholar: lookup
  52. Wang L, Liu L, Hong X, Liu D, Cheng Z. A novel method for the storage and transport of biological samples of therapeutic proteins prior to the detection of analytes using ELISA. Sci Rep 11:8763.
    doi: 10.1038/s41598-021-88180-0pmc: PMC8062679pubmed: 33888819google scholar: lookup
  53. Yan W, Saleem MH, McDonough P, McDonough SP, Divers TJ, Chang Y-F. Development of an enzyme-linked immunosorbent assay using a recombinant LigA fragment comprising repeat domains 4 to 7.5 as an antigen for diagnosis of equine leptospirosis. Clin. Vaccine Immunol. 20:1143–1149.
    doi: 10.1128/CVI.00245-13pmc: PMC3754523pubmed: 23720368google scholar: lookup
  54. Neta EIB, Brito Neto JD, Aragão CPM, Leite AKRDM. Leptospirosis in equine: a review. Rev Bras Hig E Sanidade Anim .
  55. Divers TJ, Chang Y-F, Irby NL, Smith JL, Carter CN. Leptospirosis: an important infectious disease in North American horses. Equine Vet. J. 51:287–292.
    doi: 10.1111/evj.13069pubmed: 30629756google scholar: lookup
  56. Hartskeerl RA, Collares-Pereira M, Ellis WA. Emergence, control and re-emerging leptospirosis: dynamics of infection in the changing world. Clin Microbiol Infect 17:494–501.
  57. Karpagam KB, Ganesh B. Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review. Eur J Clin Microbiol Infect Dis 39:835–846.
    doi: 10.1007/s10096-019-03797-4pubmed: 31898795google scholar: lookup

Citations

This article has been cited 0 times.